Re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2012;61:994-1003

Eur Urol. 2012 Aug;62(2):e35; author reply e36-8. doi: 10.1016/j.eururo.2012.05.022. Epub 2012 May 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use*
  • Humans
  • Lower Urinary Tract Symptoms / drug therapy*
  • Male
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Prostatic Hyperplasia / drug therapy*

Substances

  • Adrenergic alpha-Antagonists
  • Phosphodiesterase 5 Inhibitors